Ainos Inc. reports unusual stock trading and calls for NASDAQ and SEC investigations.

Ainos Inc., a healthcare firm focused on AI-driven point-of-care testing and low-dose interferon treatments, has filed complaints with NASDAQ and the SEC regarding unusual trading activities in its stock, particularly large-volume sell orders. The company suspects these trades may violate regulations and is urging a thorough investigation to ensure market fairness and protect shareholders. Ainos is committed to transparency and maintaining investor confidence amid these concerns.

November 08, 2024
5 Articles

Further Reading